(574 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Global impact of the COVID-19 on the environment
-
EAACI Guidelines on environmental health
-
The engineering-medicine interface
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
Can the birch pollen be more aggressive in the polluted environments?
-
Electronic Health in Severe Asthma
-
AIT in the pediatric population
-
Hologenome and obesity
-
Danger signs
-
How do allergens sensitize?
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Virtual care, social media and mHealth for allergy management
-
Environmental epigenomics of allergy
-
Nasal allergen challenge
-
Food allergy: new allergens on the block
-
Immunotherapy in severe asthma (AIT)
-
Measles infection causes immune amnesia
-
A patient with an acute reaction: recognize, document and treat
-
Early biomarkers for severe drug hypersensitivity reactions
-
Big changes in asthma treatment : GINA 2019
-
Update of the WAO anaphylaxis guidance
-
Over-the-counter allergy prevention weaning products
-
The ‘allergy tool kit’ for the transition clinic
-
Innate trained immunity: An evolutionary perspective
-
Phenotypes and endotypes of occupational allergy
-
Environment and Immunology StandUp TalksSpeakers ...
-
Asthma: phenotypes to endotypes
-
Launch of the Biological guidelines
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Update on drug allergy
-
Tree nut allergy: path from national to global data
-
How to improve outcomes
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Precision Medicine and AIT
-
Adherence: A challenge for Immunotherapy
-
Allergen immunotherapy for food allergy
-
When hives are not chronic urticaria
-
Therapies for multiple-tree nut allergies
-
Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
-
Mental health needs and access to care among patients with food allergy
-
Can we prevent the development of food allergy?
-
Hypereosinophilic syndromes and autoimmunity
-
Alternative free-from foods to reach a balanced diet
-
Role Viral reactivations
-
Vaccines for older adults: benefits and limitations
-
Precision medicine in immunodeficiency
-
Elderly asthma
-
The underlying immunology of pruritus
-
Real-life evidence of the burden of chronic rhinosinusitis (CRS)
-
Social media and Allergies: how can we support our patients?
-
Implementation of telehealth in asthma management: trials and tribulations
-
Immunological basis of food aversion
-
What’s different about the adolescent brain?
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
Collective advocacy for action on CRDs
-
Targeted approaches for asthma
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Structural biology of food allergens and cross reactivity
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Psychological support to peanut allergic children and their families
-
Hypersensitivity to antiepileptic drugs
-
A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC)
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Differential diagnosis
-
Late onset T2 asthma – a case study
-
The clinical clues and pitfalls in contact dermatitis
-
Telemedicine and Tele-health
-
The dilemma of food allergy additives
-
Predicting adverse reactions to biologicals
-
Should we do patch testing in children with eczema?
-
Novel cell based assays in allergy diagnostics
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Is anaphylaxis really rare in children?
-
How to evaluate lung function? Hands-on plus lecture
-
Molecular allergology in daily clinical practice
-
Gut microbiome - based therapeutic approaches
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Mechanisms of non IgE mediated food allergy
-
Oral food challenge versus biomarkers - are challenges still needed?
-
Endotype-driven treatment in chronic rhinosinusitis
-
Evidence of immunotherapy on allergy prevention?
-
Allergy to Kale
-
Lung function testing
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
What do we learn from subgroup analyses in phase-III trials?
-
The role of infection in chronic spontaneous urticaria
-
Epithelial cell barrier and allergic diseases
-
Desensitization in chemotherapy and biologics
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Updates in [severe] asthma in adults
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Difficult to control asthma in children
-
Precision medicine and biomarkers of atopic dermatitis
-
Novel therapeutic approaches targeting endotypes of severe airway disease
-
The basics of severe asthma - biomarkers
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
We are what we eat - importance of food to health, moving past simple calories
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
New and clinically relevant contact allergens
-
2'FL and LNnT shape the gut microbiome and metabolome in CMPA
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
AAAAI Practice Parameters
-
Moisturisers for the primary prevention of food allergy
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
Challenges on the implementation of early introduction of allergenic foods
-
Diagnosis of insect venom allergy: back to basics
-
Do adrenaline auto-injectors save lives?
-
Proton pump inhibitor responsive esophageal eosinophilia is this EoE or not EoE (Pro & Con Session: Con)
-
Proton pump inhibitor responsive esophageal eosinophilia is this EoE or not EoE (Pro & Con Session: Pro)
-
Airborne enzymes – New and re-emerging occupational hazards
-
Asma e alergia em Angola
-
Role of antigen-presenting cells in tolerance and allergy
-
Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids
-
Big data and cluster analysis: a real life perspective
-
Sleep patterns and development of children with atopic dermatitis
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
Cellular tests for the diagnosing and monitoring of allergy
-
GINA Guidelines Update
-
Treating allergic patients during the COVID-19 pandemic
-
Potential biomarkers for diagnosis and treatment for CSU
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Asthma management during the COVID-19 pandemics
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents
-
Oral food challenges thresholds for clinical reactions
-
Urban green spaces - The exposure and allergenicity index
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Food industry perspective
-
Food allergy - the beginners guide
-
Viral infection and asthma
-
Tezepelumab (anti-TSLP) in asthma
-
Impact of climate change on the immune system
-
Living with food allergy
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
Route of exposure determines the immune response to food allergens
-
Preparing a grant: Dos and Don'ts
-
The brain, nose, immune axis
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Impact of food allergy on household expenditures among Manitoba families
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
What is the immunological basis for new biologicals?
-
Molecular and structural considerations for aerosolization of food allergens
-
Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life
-
Impact of climate change on asthma exacerbations
-
AI models
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Understanding parent preferences for paediatric allergy services
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
AIT, Biologicals and Covid vaccination
-
Fast acting disruptive IgE inhibitors rapidly desensitize allergic effector cells and resolve IgE-mediated anaphylaxis
-
How to improve compliance of allergen immunotherapy in the clinic?
-
FAAM-EUROBAT Opening ceremony
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Immune responses in desentitization and tolerance
-
Vaccines- Is this the tool to end the pandemic?
-
Big Data Analysis: MetabolomicsView Presentation
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
Food elimination diet in eosinophilic esophagitis and other eosinophilic gastrointestinal disorders (Clinical cases)
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Phenotypes and Endotypes
-
Tackling anaphylaxis
-
Developing an adolescent and young adult allergy service
-
Neuroimmunology and allergy
-
Risk assessment and active management of food allergy
-
New insights in urticaria mechanisms
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Exercise: induced asthma and rhinitis
-
E-cigarettes: mechanistic link to lung injury
-
Assessment of adherence to treatment using mHealth
-
Management of adverse reactions to biologics
-
Unusual presentations of contact dermatitis
-
Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations
-
Inflammatory biomarkers
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
Novel approaches of allergen immunotherapy
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Novel pharamacological targets
-
Is IgA a piece of the EoE puzzle?
-
Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Precision Medicine and integrated care pathways in 2020 and beyond
-
Difficult to control asthma in adults
-
Skin care from birth for allergy prevention: results today
-
